Corneal depositions in tyrosinaemia type I during treatment with Nitisinone

7Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

We present a 17-year-old boy, diagnosed with tyrosinaemia type I at an age of 7 months, with new complaints of severe intermittent photophobia and burning eyes. His tyrosinaemia type I is treated with nitisinone and a protein-restricted diet. Dietary compliance is low since he entered puberty. His ocular complaints are attributable to subepithelial corneal deposits, resembling the common corneal phenotype of tyrosinaemia type II. Serum tyrosine levels were markedly elevated. Tyrosinaemia is a metabolic disease of tyrosine metabolism, subdivided into two types. Corneal deposits and photophobia are cardinal features of untreated tyrosinaemia type II, but not of type I. Novel treatment strategies (with nitisinone) for type I tyrosinaemia lead to a phenotype comparable with type II, including these corneal deposits. At follow-up visits his ocular complaints unfortunately remained unchanged, though he states his dietary compliance improved through the years. Copyright 2012 BMJ Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Wisse, R. P. L., Wittebol-Post, D., Visser, G., & Van Der Lelij, A. (2012). Corneal depositions in tyrosinaemia type I during treatment with Nitisinone. BMJ Case Reports. https://doi.org/10.1136/bcr-2012-006301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free